Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium avium Complex (MAC)

References

• Griffith DE, Aksamit TR. Therapy of refractory nontuberculous mycobacterial lung disease. Curr Opin Infect Dis. 2012;25(2):218–227. doi:10.1097/QCO.0b013e3283511a64
   PubMed Web of Science ®Google Scholar
• Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36(1):13–34. doi:10.1016/j.ccm.2014.10.002
   PubMed Web of Science ®Google Scholar
• Stout JE, Koh WJ, Yew WW. Update on pulmonary disease due to non-tuberculous mycobacteria. Int j Infect Dis. 2016;45:123–134.
   PubMed Web of Science ®Google Scholar
• Hoefsloot W, van Ingen J, Andrejak C, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604–1613.
   PubMed Web of Science ®Google Scholar
• Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis. 2014;6(3):210–220.
   PubMed Web of Science ®Google Scholar
• Diel R, Lipman M, Hoefsloot W. High mortality in patients with Mycobacterium avium complex lung disease: a systematic review. BMC Infect Dis. 2018;18(1):206.
   PubMed Web of Science ®Google Scholar
• Park HY, Jeong BH, Chon HR, Jeon K, Daley CL, Koh WJ. Lung Function Decline According to Clinical Course in Nontuberculous Mycobacterial Lung Disease. Chest. 2016;150(6):1222–1232.
   PubMed Web of Science ®Google Scholar
• Mehta M, Marras TK. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med. 2015;105(11):1718–1725.
   Web of Science ®Google Scholar
• Asakura T, Funatsu Y, Ishii M, et al. Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients. Respir Res. 2015;16:145.
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST
   PubMed Web of Science ®Google Scholar
• Hong JY, Lee SA, Kim SY, et al. Factors associated with quality of life measured by EQ-5D in patients with nontuberculous mycobacterial pulmonary disease. Quality Life Res. 2014;23(10):2735–2741. doi:10.1007/s11136-014-0727-3
   Web of Science ®Google Scholar
• Griffith DE, Eagle G, Thomson R, et al. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018;198(12):1559–1569. doi:10.1164/rccm.201807-1318OC
   PubMed Web of Science ®Google Scholar
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117. doi:10.1164/ajrccm.166.1.at1102
   PubMed Web of Science ®Google Scholar
• Miller MR, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. doi:10.1016/0168-8510(90)90421-9
   PubMed Web of Science ®Google Scholar
• American Society for Radiation Oncology (ASTRO). Coding Tip: gynecologic Brachytherapy Procedures. Available from: https://www.astro.org/Daily-Practice/Coding/Coding-Guidance/FAQ-Coding-Tips. Accessed July 4, 2019.
   Google Scholar
• Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–1108. doi:10.1097/00005650-199711000-00002
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. george’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.1321
   PubMed Web of Science ®Google Scholar
• Pompilus F, Burgess S, Hudgens S, Banderas B, Daniels S. Development and validation of a novel patient-reported treatment satisfaction measure for hyperfunctional facial lines: facial line satisfaction questionnaire. J Cosmet Dermatol. 2015;14(4):274–285. doi:10.1111/jocd.12166
   PubMed Web of Science ®Google Scholar
• Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health. 2007;10(Suppl 2):S94–s105. doi:10.1111/j.1524-4733.2007.00272.x
   PubMed Web of Science ®Google Scholar
• Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health. 2008;11(2):322–333. doi:10.1111/j.1524-4733.2007.00231.x
   PubMed Web of Science ®Google Scholar
• Encyclopedia of Quality of Life and Well-Being Research: Known-Groups Validity. Available from: https://link.springer.com/referenceworkentry/10.1007%2F978-94-007-0753-5_1581. Accessed September 3, 2019.
   Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Eng J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa021322
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences. Academic Press. 1988;2:254.
   Google Scholar
• Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31(2):416–469. doi:10.1183/09031936.00099306
   PubMed Web of Science ®Google Scholar
• Jones PW. St. George’s Respiratory Questionnaire: MCID. COPD. 2005;2(1):75–79. doi:10.1081/COPD-200050513
   PubMedGoogle Scholar
• Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients.. Am J Respir Crit Care Med. 1997;155(4):1278–1282. doi:10.1164/ajrccm.155.4.9105067
   PubMed Web of Science ®Google Scholar
• de Morton NA, Davidson M, Keating JL. Validity, responsiveness and the minimal clinically important difference for the de Morton Mobility Index (DEMMI) in an older acute medical population. BMC Geriatr. 2010;10(1):72. doi:10.1186/1471-2318-10-72
   PubMed Web of Science ®Google Scholar
• Hays RD. D R. Reliability and validity (including responsiveness). In: Assessing Quality of Life in Clinical Trials: Methods and Practice USA. Oxford University Press; 2005:35.
   Google Scholar
• Roach KE. Measurement of Health Outcomes: Reliability, Validity and Responsiveness. JPO. 2006;18(6):P8–P12.
   Google Scholar
• Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med. 2008;102(4):519–536.
   PubMed Web of Science ®Google Scholar
• Lin FJ, Pickard AS, Krishnan JA, et al. Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form. BMC Med Res Methodol. 2014;14:78.
   PubMed Web of Science ®Google Scholar
• Nolan CM, Longworth L, Lord J, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493–500.
   PubMed Web of Science ®Google Scholar
• Stahl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005;3:56.
   PubMedGoogle Scholar
• Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006;130(4):1117–1128.
   PubMed Web of Science ®Google Scholar
• Solem CT, Vera Llonch M, Liu S, et al. Responsiveness of the Eq-5D index and visual analog scale to changes in lung function in patients with cystic fibrosis. Value in Health. 2014;17(3):A178.
   Web of Science ®Google Scholar
• Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4):822–832.
   PubMed Web of Science ®Google Scholar
• Vinnard C, Mezochow A, Oakland H, Klingsberg R, Hansen-Flaschen J, Hamilton K. Assessing response to therapy for nontuberculous mycobacterial lung disease: quo vadis? Front Microbiol. 2018;9:2813.
   Web of Science ®Google Scholar
• Payakachat N, Ali MM, Tilford JM, EQ- CT. 5D detect meaningful change? A systematic review. PharmacoEconomics. 2015;33(11):1137–1154.
   PubMed Web of Science ®Google Scholar
• Szende A, Leidy NK, Stahl E, Svensson K. Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Quality Life Res. 2009;18(2):267–272.
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan VH, Campbell JD, Globe G, Bender B, Magid DJ. Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes. Quality Life Res. 2016;25(12):3017–3026.
   PubMed Web of Science ®Google Scholar
• Yang Y, Rowen D, Brazier J, Tsuchiya A, Young T, Longworth L. An exploratory study to test the impact on three “bolt-on” items to the EQ-5D. Value Health. 2015;18(1):52–60.
   PubMed Web of Science ®Google Scholar
• Hoogendoorn M, Oppe M, Boland MRS, Goossens LMA, Stolk EA, Rutten-van Molken M. Exploring the impact of adding a respiratory dimension to the EQ-5D-5L. Med Decision Making. 2019;39(4):393–404.
   Web of Science ®Google Scholar
• Gandhi M, Thumboo J, Luo N, Wee HL, Cheung YB. Do chronic disease patients value generic health states differently from individuals with no chronic disease? A case of a multicultural Asian population. Health Qual Life Outcomes. 2015;13:8.
   PubMed Web of Science ®Google Scholar